+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mesenchymal Stem Cells Market by Application, Source, End User, Product Type, Culture Method, Therapy Type - Global Forecast to 2030- Product Image
Mesenchymal Stem Cells Market by Application, Source, End User, Product Type, Culture Method, Therapy Type - Global Forecast to 2030- Product Image
Sale

Mesenchymal Stem Cells Market by Application, Source, End User, Product Type, Culture Method, Therapy Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5518254
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mesenchymal stem cells market is rapidly advancing, driven by breakthroughs in regenerative medicine and persistent demand for novel therapies in diverse clinical areas. Organizations seeking competitive advantage must align with evolving technologies, regulatory frameworks, and sophisticated supply chain strategies to fully realize the sector’s commercial potential.

Market Snapshot: Mesenchymal Stem Cells Market

The mesenchymal stem cells market grew from USD 3.98 billion in 2024 to USD 4.55 billion in 2025. It is expected to continue growing at a CAGR of 13.67%, reaching USD 8.60 billion by 2030. This robust growth underscores expanding clinical applications, increased investment in bioprocessing, and a maturing regulatory landscape. Expansion spans established medical hubs and emerging regions, as stem cell therapies gain traction for autoimmune, cardiovascular, orthopedic, and neurological treatments. Strategic collaborations between biotech firms, research institutes, and healthcare organizations foster innovation and fuel the development of both autologous and allogeneic solutions.

Scope & Segmentation

This report comprehensively breaks down the dynamic mesenchymal stem cells market, enabling stakeholders to act on granular insights across all value chain tiers. Coverage includes the following segments:

  • Application Areas: Autoimmune disorders, cardiovascular disease, diabetes, neurology, orthopedics, regenerative medicine, wound healing
  • Cell Sources: Adipose tissue, bone marrow, dental pulp, placenta, umbilical cord
  • End Users: Cell banks and biorepositories, contract research organizations, hospitals and clinics, pharmaceutical and biotech companies, research institutes
  • Product Types: Instruments and accessories, kits and reagents (enzymes and dissociation reagents, growth factors and cytokines, media and supplements, surface markers and antibodies), services
  • Culture Methods: Bioreactor systems (fixed-bed, hollow-fiber, stirred tank), three-dimensional culture (hydrogels, scaffolds, spheroids), two-dimensional culture
  • Therapy Type: Allogeneic and autologous
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, and others), and Asia-Pacific (China, India, Japan, Australia, and others)
  • Company Coverage: Analysis includes Mesoblast Limited, Pluristem Therapeutics Inc., Athersys, Inc., Lonza Group AG, STEMCELL Technologies Inc., Cellular Biomedicine Group, Cynata Therapeutics Limited, Anterogen Co., Vericel Corporation, SanBio Co., Ltd.

Key Takeaways for Decision-Makers

  • Leading organizations are leveraging advanced gene editing, real-time analytics, and automated manufacturing platforms to improve cell potency and therapy reliability across applications.
  • Strategic investment in flexible manufacturing and local sourcing empowers companies to respond quickly to regulatory changes and shifting supply conditions.
  • Alliances with domestic suppliers and the establishment of onshore reagent production support risk mitigation in response to evolving trade policies and tariff impacts.
  • Segment preferences for cell sources are informed by considerations such as scalability, ethical sourcing, and immunogenicity—each influencing product development and adoption pathways.
  • Emerging regional hubs are accelerating R&D through government incentives and robust funding, making the Asia-Pacific region an increasingly critical player in both clinical trial activity and manufacturing scale.
  • Pioneering market entrants focus on specialized applications such as neuroregeneration and immuno-oncology, driving new avenues for therapy adoption and partnership.

Tariff Impact on the US Market

In 2025, the introduction of new tariffs on core materials—reagents, bioreactor components, and specialized instrumentation—led US-based developers to reassess sourcing strategies and bolster localized manufacturing. This has stimulated domestic supply alliances while pushing some firms to boost operational efficiency through process optimization and supply chain risk management.

Methodology & Data Sources

The research behind this report utilized primary interviews with industry and regulatory leaders and a comprehensive review of secondary sources, including peer-reviewed journals and regulatory filings. Methodological rigor was ensured through data triangulation, peer validation, and cross-comparison of quantitative and qualitative findings with subject-matter expertise at every stage.

Why This Report Matters

  • Enables informed capital allocation by identifying where scientific and commercial innovation are most concentrated across applications, regions, and business models.
  • Equips senior stakeholders with a clear view of evolving regulatory landscapes and actionable strategies for maintaining pricing stability and accelerating time-to-market.
  • Provides benchmarking for competitive positioning within the global mesenchymal stem cells market across all major and emerging therapeutic domains.

Conclusion

Senior leaders equipped with this analysis are positioned to navigate the mesenchymal stem cells market’s dynamic growth, regulatory change, and regional shifts. Informed strategic adaptation will be essential for capturing near-term opportunities and sustaining long-term impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mesenchymal Stem Cells Market, by Application
8.1. Introduction
8.2. Autoimmune Disorders
8.3. Cardiovascular
8.4. Diabetes
8.5. Neurology
8.6. Orthopedics
8.7. Regenerative Medicine
8.8. Wound Healing
9. Mesenchymal Stem Cells Market, by Source
9.1. Introduction
9.2. Adipose Tissue
9.3. Bone Marrow
9.4. Dental Pulp
9.5. Placenta
9.6. Umbilical Cord
10. Mesenchymal Stem Cells Market, by End User
10.1. Introduction
10.2. Cell Banks & Biorepositories
10.3. Contract Research Organizations
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotech Companies
10.6. Research Institutes
11. Mesenchymal Stem Cells Market, by Product Type
11.1. Introduction
11.2. Instruments & Accessories
11.3. Kits & Reagents
11.3.1. Enzymes & Dissociation Reagents
11.3.2. Growth Factors & Cytokines
11.3.3. Media & Supplements
11.3.4. Surface Markers & Antibodies
11.4. Services
12. Mesenchymal Stem Cells Market, by Culture Method
12.1. Introduction
12.2. Bioreactor Systems
12.2.1. Fixed-Bed
12.2.2. Hollow-Fiber
12.2.3. Stirred Tank
12.3. Three-Dimensional Culture
12.3.1. Hydrogels
12.3.2. Scaffolds
12.3.3. Spheroids
12.4. Two-Dimensional Culture
13. Mesenchymal Stem Cells Market, by Therapy Type
13.1. Introduction
13.2. Allogeneic
13.3. Autologous
14. Americas Mesenchymal Stem Cells Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Mesenchymal Stem Cells Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Mesenchymal Stem Cells Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Mesoblast Limited
17.3.2. Pluristem Therapeutics Inc.
17.3.3. Athersys, Inc.
17.3.4. Lonza Group AG
17.3.5. STEMCELL Technologies Inc.
17.3.6. Cellular Biomedicine Group, Inc.
17.3.7. Cynata Therapeutics Limited
17.3.8. Anterogen Co., Ltd.
17.3.9. Vericel Corporation
17.3.10. SanBio Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. MESENCHYMAL STEM CELLS MARKET MULTI-CURRENCY
FIGURE 2. MESENCHYMAL STEM CELLS MARKET MULTI-LANGUAGE
FIGURE 3. MESENCHYMAL STEM CELLS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MESENCHYMAL STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DENTAL PULP, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PLACENTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CELL BANKS & BIOREPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ENZYMES & DISSOCIATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY MEDIA & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SURFACE MARKERS & ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FIXED-BED, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HOLLOW-FIBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STIRRED TANK, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SPHEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TWO-DIMENSIONAL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 75. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 76. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 77. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 78. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 81. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 85. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 131. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 139. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 140. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 141. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 142. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 152. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 154. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 157. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 158. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 159. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 160. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 163. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 167. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 168. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 197. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 199. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 202. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 203. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 204. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 215. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 217. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 220. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 221. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 222. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 223. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 226. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 229. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 230. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 231. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 232. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 251. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 253. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 256. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 257. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 258. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 259. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 265. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 266. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 267. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 268. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 280. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 283. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 284. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 285. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 286. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 287. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 289. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 292. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 293. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 294. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 295. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 312. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 313. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 314. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 315. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 317. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 320. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 321. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY BIOREACTOR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 322. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY THREE-DIMENSIONAL CULTURE, 2018-2030 (USD MILLION)
TABLE 323. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 324. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 326. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 329. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY CULTURE METHOD, 2018-2030 (USD MILLION)
TABLE 330. IN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mesenchymal Stem Cells market report include:
  • Mesoblast Limited
  • Pluristem Therapeutics Inc.
  • Athersys, Inc.
  • Lonza Group AG
  • STEMCELL Technologies Inc.
  • Cellular Biomedicine Group, Inc.
  • Cynata Therapeutics Limited
  • Anterogen Co., Ltd.
  • Vericel Corporation
  • SanBio Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.55 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.6 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030 - Product Image

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Mesenchymal Stem Cells Market Report 2025 - Product Image

Mesenchymal Stem Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mesenchymal Stem Cell Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Mesenchymal Stem Cell Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 94 Pages
  • Global
From
Mesenchymal Stem Cells (MSC) - Global Strategic Business Report - Product Image

Mesenchymal Stem Cells (MSC) - Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From

About the Mesenchymal Stem Cell Market

The Mesenchymal Stem Cell (MSC) market is a rapidly growing sector of the genomics industry. MSCs are multipotent cells that can differentiate into a variety of cell types, including bone, cartilage, and fat. They are used in regenerative medicine, tissue engineering, and drug discovery. MSCs are also being studied for their potential to treat a variety of diseases, including cancer, autoimmune disorders, and cardiovascular diseases. The MSC market is driven by advances in genomics technology, such as gene editing and sequencing, which have enabled researchers to better understand the biology of MSCs and develop new therapeutic applications. Additionally, the increasing demand for personalized medicine and the growing awareness of the potential of MSCs to treat a variety of diseases are driving the growth of the MSC market. Some of the major companies in the MSC market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, STEMCELL Technologies, and Cellular Dynamics International. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.